Cao Qi, Bai Peng
Department of Urology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
Department of Cardiovascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
J Cancer. 2019 Jun 2;10(11):2501-2509. doi: 10.7150/jca.29285. eCollection 2019.
Autophagy is a highly conserved catabolic process with critical functions in maintenance of cellular homeostasis under normal growth conditions and in preservation of cell viability under stress. The role of autophagy in cancer is dual-sided. Autophagy-deficient cells are often more tumorigenic than their wild type counterparts in association with DNA damage accumulation, oxidative stress. At the same time, autophagy is a major cell survival mechanism. In recent years, it has been well demonstrated that autophagy may have relation with renal cell carcinoma (RCC). This review focuses on the research progress in relation between autophagy and RCC and the pharmacologic manipulation of autophagy for RCC treatment.
自噬是一种高度保守的分解代谢过程,在正常生长条件下维持细胞稳态以及在应激状态下保持细胞活力方面具有关键作用。自噬在癌症中的作用是双重的。自噬缺陷细胞通常比野生型细胞更具致瘤性,这与DNA损伤积累、氧化应激有关。同时,自噬是一种主要的细胞存活机制。近年来,已有充分证据表明自噬可能与肾细胞癌(RCC)有关。本综述重点关注自噬与RCC关系的研究进展以及自噬在RCC治疗中的药物调控。